A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/095 (2006.01) C07K 19/00 (2006.01) C12N 1/20 (2006.01)
Patent
CA 2747340
The meningococcal haemoglobin receptor, HmbR, is used as a vaccine antigen in combination with one or more further antigens e.g. in combination with a meningococcal outer membrane vesicle, with another purified meningococcal antigen (e.g. fHBP, 287, NadA, NspA, NhhA, App, Omp85, LOS), with a conjugated meningococcal capsular saccharide, etc.
Selon l'invention, le récepteur de l'hémoglobine méningococcique, HmbR, est utilisé en tant qu'antigène vaccinal combiné avec un ou plusieurs autres antigènes, par exemple combiné à une vésicule membranaire externe méningococcique, à un autre antigène méningococcique purifié (par exemple, fHBP, 287, NadA, NspA, NhhA, App, Omp85, LOS), à un saccharide capsulaire méningococcique conjugué etc.
Arico Beatrice Maria
Rappuoli Rino
Scarselli Maria
Borden Ladner Gervais Llp
Novartis Ag
LandOfFree
Meningococcal vaccines including hemoglobin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Meningococcal vaccines including hemoglobin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meningococcal vaccines including hemoglobin receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2076296